ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%
Mon, 27 May

ASTRAZENECA PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m1,5072,1521,903-11.6%26.3%
Other incomeRs m23356072.0%157.1%
TurnoverRs m1,5312,1871,963-10.2%28.3%
ExpensesRs m1,3551,7431,8395.5%35.8%
Gross profitRs m15340964-84.4%-58.3%
DepreciationRs m3638393.4%10.1%
InterestRs m0000.0%0.0%
Profit before taxRs m14140685-79.1%-39.7%
TaxRs m108115-14-111.7%-112.5%
Profit after taxRs m3229198-66.2%204.9%
Gross profit margin%10.119.03.3
Effective tax rate%77.128.3-15.9
Net profit margin%2.113.35.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 26.3% on a year-on-year (YoY) basis. The expenses were up by 35.8% YoY during the same period.
  • The company's operating profit declined by 58.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 10.1% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 157.1% YoY during the quarter.
  • Net profit for the quarter increased by 204.9% YoY. Net profit margins during the quarter increased from 2.1% in 4QFY18 to 5.0% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.5% QoQ during the same period.
  • The company's operating profit declined by 84.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 19.0% in 3QFY18.
  • Net profit for the quarter declined by 66.2% QoQ, while net profit margins declined from 13.3% in 3QFY18 to 5.0% in 4QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,194.6 to Rs 2,089.9, registering a Gain of Rs 895.4 or around 75.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,392.0 (down 0.0%). Over the last one year it has moved up from 13,044.2 to 13,392.0, a gain of 348 points (up 2.7%).

Overall, the S&P BSE SENSEX is up 14.3% over the year.

Current Valuations

At the current price of Rs 2,089.9, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.2 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


May 10, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - NEULAND LABS COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS